Five major associations jointly signed "petition" for reform of new regulations on drug trade in Guangdong Province

Source: on June 7, 2013, five associations of Yangcheng Evening News questioned that the new regulation is a new form of "only low price is to take", and called for the revision of "drug trading rules of Guangdong Province (Trial) (Draft for comments)" issued on May 17, which has ended consultation, but still attracted a lot of controversy Yesterday, the reporter of Yangcheng Evening News learned from the China Pharmaceutical Enterprise Management Association that five first-class industry associations in China have jointly written to the relevant government departments to put forward a large number of amendments to the new regulations on drug trade in Guangdong, many of which have made a fierce attack on many terms and called for "fundamental amendments" Yesterday, Yu Mingde, President of China Pharmaceutical Enterprise Management Association, confirmed to reporter of Yangcheng Evening News that "only low price is price" At the beginning of the month, five pharmaceutical industry associations, including China Pharmaceutical Enterprise Management Association, China traditional Chinese Medicine Association, China Pharmaceutical Industry Research and Development Promotion Association, China over the counter Pharmaceutical Association, and China Chemical Pharmaceutical Industry Association, jointly submitted to the Legislative Affairs Office of the State Council, the national development and Reform Commission, the Ministry of industry and information technology, the Ministry of finance, the Ministry of human resources and social security, the health and Family Planning Commission, the General Administration of pharmaceutical supervision, and the people's Government of Guangdong Province A proposal on "Guangdong drug trading rules (Trial) (Draft for comments)", etc Among them, "only low price is to take", drug quality level division, bidding frequency, dosage form combination bidding, low price drug definition, etc are the focus of the five associations According to five industry associations, the new regulations on drug trade in Guangdong is a new form of "only low price is taking" For example, in the non essential drug trade, we take a simple quality level division, choose the lowest price as the trading variety, and completely give up the determination of the winning enterprise through comprehensive evaluation Although the comprehensive evaluation of economic and technical bid and commercial bid has been adopted in the bidding of essential drugs, the economic and technical bid only accounts for 10% of the weight, and the price accounts for 90% Basically, the lowest bidder wins the bid According to the five major industry associations, the new drug trade regulations fail to take into account the objective fact that there are different management levels and quality differences between the same kind of drugs in China's pharmaceutical enterprises Without quality evaluation, the lowest price is always the transaction price, which is a negative and blow to the enterprises that actively improve the quality of drugs Will some of the opinions or opinions to be adopted be taken seriously? It is reported that the new regulations on drug trade in Guangdong Province have been discussed at a meeting after public consultation, and the formed draft has been submitted to the superior leaders, and the final draft is planned to be released this month "Compared with the draft for comments, some reasonable opinions should be adopted in the final draft, but the core transaction rules will not be changed greatly After all, the drug bidding reform in Guangdong is also agreed by the state, which represents one of the major directions of medical reform." Some insiders said At the same time, there are market rumors that the Guangdong Provincial Department of health has signed a contract with the South united property rights trading center and the South Institute of pharmaceutical economics of the State Food and drug administration to undertake the third-party electronic drug trading platform, and the Guangdong drug exchange will officially open as soon as July this year